drugset / Trial / NCT01044992

Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study

NCT01044992

Completed 38 enrolled University Hospital, Toulouse
RandomizedParallel-groupDouble-blindBasic science

Summary

Background: Multiple System Atrophy (MSA) is an atypical parkinsonian syndrome including cerebellar impairment and poor response to dopatherapy. The objective of the study is to assess right-hand motor activation in MSA patients before and after an acute levodopa challenge and to compare these data with those obtained in patients with Parkinson Disease (PD) and healthy volunteers (HV). Methods: Eighteen MSA patients, eight PD patients and 10 age-matched HV will be included. rCBF measurements with H215O PET will be performed at rest and during a right hand movement. Statistical parametric mapping will be used to analyze motor versus rest in OFF and ON condition and effect of levodopa on motor activation. Hypothesis: MSA and PD patient should recruited different motor networks.

Timeline

Start
2002-05
Primary completion
2005-05
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodopa Small molecule 200 mg Oral